Comparative analysis of the impact of e-cigarette vapor and cigarette smoke on human gingival fibroblasts.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 19 06 2020
revised: 01 08 2020
accepted: 16 09 2020
pubmed: 22 9 2020
medline: 10 8 2021
entrez: 21 9 2020
Statut: ppublish

Résumé

Human gingival fibroblasts (HGF) play a vital role in wound healing, oral cancer, and are among the first cells being exposed to e-cigarette vapor (eCV) or cigarette smoke (CS) during inhalation. Although the cell-damaging effect of CS has been well studied, the effects of eCV on gingival cells are still unclear. The aim of this in vitro study was to compare the effects of eCV and CS on HGF in terms of proliferation, metabolic activity, cell death, and formation of reactive oxygen species (ROS). After 24 h cell numbers in CS-exposed cells in contrast to eCV-exposed cells were significantly decreased compared to the control. At later points in time, such differences could no longer be observed. Compared to the control, HGF stimulated with eCV showed a significantly higher metabolic activity 1 h, 24 h, and 48 h after exposure. 24 h after exposure, the metabolic activity was increased in both test groups. No caspase 3/7 activation nor significant differences in the amount of apoptosis/necrosis among the groups were seen. Only in CS-exposed cells ROS formation was increased at 1 h, 3 h, and 6 h after exposition. In conclusion, when compared to conventional CS, a less harmful effect of eCV on HGF can be assumed.

Identifiants

pubmed: 32956835
pii: S0887-2333(20)30555-5
doi: 10.1016/j.tiv.2020.105005
pii:
doi:

Substances chimiques

E-Cigarette Vapor 0
Reactive Oxygen Species 0
Smoke 0
CASP3 protein, human EC 3.4.22.-
CASP7 protein, human EC 3.4.22.-
Caspase 3 EC 3.4.22.-
Caspase 7 EC 3.4.22.-

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105005

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare that they have no conflict of interest.

Auteurs

M F Vermehren (MF)

Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131 Mainz, Germany.

N Wiesmann (N)

Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131 Mainz, Germany; Department of Otorhinolaryngology, University Medical Centre Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. Electronic address: nwiesman@uni-mainz.de.

J Deschner (J)

Department of Periodontology and Operative Dentistry, University Medical Centre Mainz, Augustusplatz 2, 55131 Mainz, Germany.

J Brieger (J)

Department of Otorhinolaryngology, University Medical Centre Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.

B Al-Nawas (B)

Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131 Mainz, Germany.

P W Kämmerer (PW)

Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131 Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH